相关实验视频
Updated: Jun 19, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.5K
与瘤相关的巨细胞:瘤微环境中的先天性免疫系统的哨兵变得疯狂
Shaivy Malik1, Niti Sureka1, Sana Ahuja1
1Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, New Delhi, India.
Cell biology international
|July 26, 2024
概括
瘤相关巨细胞 (TAMs) 是癌症的关键参与者,影响瘤生长和治疗. 重编程TAM和使用化学抗原受体巨细胞 (CAR-M) 显示出有效的癌症治疗的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 瘤微环境 (TME) 极大地影响癌症的发病,进展和治疗反应.
- 瘤相关巨细胞 (TAMs) 在TME中表现出可塑性,充当瘤生长的促进者和抑制者.
- TAMs的亲瘤功能包括促进血管生成,免疫抑制和转移.
研究的目的:
- 审查TAMs在瘤微环境中的多方面的作用.
- 探索针对TAM的治疗策略,重点关注重编程和新的方法.
- 讨论化学抗原受体巨细胞 (CAR-M) 在固体瘤治疗中的潜力.
主要方法:
- 对TAM功能和治疗干预措施的文献综述.
- 对TAM向疗法的临床前和临床数据的分析.
- 对巨细胞 (CAR-M) 应用的化学抗原受体 (CAR) 技术的探索.
主要成果:
- TAMs表现出可塑性,采用可以促进或抑制瘤进展的表型.
- 像CSF1R抑制剂,CD40激动剂和CD47阻断等治疗策略在调节TAMs方面表现有前途.
- 化学抗原受体-巨细胞 (CAR-M) 代表了一种针对固体瘤的新方法,第三代技术正在不断发展.
结论:
- 了解TME中的TAM动态对于开发有效的癌症疗法至关重要.
- 重编程TAM和利用CAR-M技术为癌症治疗提供了有前途的途径.
- 进一步的研究和临床试验对于优化TAM向策略和改善患者治疗结果至关重要.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

